Last update:
Oncology news
Air pollution-linked blood changes detected years before lung cancer diagnosis
A new study, published Tuesday in Nature Communications, found measurable changes in people's blood associated with exposure to air pollution and the subsequent development of lung cancer. The findings provide promising clues ...
11 hours ago
0
4
Cell-surface receptors guide antisense therapy to mutant KRAS in pancreatic cancer cells
Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer. In a study published in the Journal of Cell Biology ...
19 hours ago
0
5
Thyroid's two hormone-producing cell types develop separately before merging, study finds
The thyroid gland consists of two types of hormone-producing cells that regulate the body's metabolism and calcium balance. In mammals, these cell types merge into a single organ, whereas in other vertebrates, they develop ...
16 hours ago
0
4
Q&A: Lowering radiation dose in chest X-ray imaging yields same accuracy, researcher finds
Digital tomosynthesis (DTS) is an X-ray technique that provides sectional images with better lesion visibility than conventional chest radiography (CXR), while using far less radiation than CT. Masoud Jadidi will defend his ...
14 hours ago
0
2
Single blood test could provide more information about cancer
A single blood test could in the future provide a more comprehensive picture of cancer than current methods. In a review article published in the journal Genome Medicine, researchers at Karolinska Institutet describe how ...
14 hours ago
0
2
Differences in immune cells predict skin cancer treatment outcomes
In a first-of-its-kind study by King's College London, researchers have linked changes in two major types of immune cells in blood to different survival outcomes for patients with melanoma. Melanoma, the fifth most common ...
18 hours ago
0
2
Prostate cancer prognosis linked to prostate-specific antigen levels below threshold
After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below ...
Aug 10, 2026
0
2289
Simple blood test on a chip could help diagnose lung cancer
Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing. The method identifies a chemical fingerprint of cancer cells ...
Aug 10, 2026
0
31
Patient-derived organoids reveal which breast tumors may resist standard therapies
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown ...
Aug 10, 2026
0
13
An 'energy addiction' in high-risk blood cancer stem cells could lead to new treatment strategies
Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes (MDS), a discovery that could lead ...
Aug 10, 2026
0
7
AI model maps tumor tissue to improve cancer care
A tumor is more than its cancer cells. Immune cells, blood vessels and other surrounding tissue influence how a cancer grows and responds to treatment. Two tumors containing the same cell types can respond very differently ...
Aug 10, 2026
0
6
Fifteen minutes more movement linked to 2% lower cancer risk
Replacing 15 minutes of sleep or sedentary behavior with 15 minutes of movement was each linked to a 2% reduced risk of cancer, new UCL research has found.
Aug 10, 2026
0
7
New analysis explains why bone marrow cancer T cells may need therapeutic activation
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow of patients ...
Aug 10, 2026
0
4
MBNL1 identified as a potential cancer drug target for a type of childhood leukemia
Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements. The ...
Aug 10, 2026
0
5
Traditional prostate cancer risk factors do not predict hormone therapy benefit, study finds
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as high-grade disease, cancer extending ...
Aug 10, 2026
0
134
Where women live may influence ovarian cancer survival, especially among Black women
A new study led by researchers at the University of Pittsburgh found that women living in socially vulnerable communities face a 20% higher risk of death after an ovarian cancer diagnosis compared with women living in less ...
Aug 10, 2026
0
4
New melanoma drug based on herpes virus granted FDA accelerated approval
Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma—giving doctors another weapon to fight this challenging skin cancer.
Aug 10, 2026
0
8
How a Veterans Affairs study can help guide prostate cancer treatment
A nationwide Veterans Affairs (VA) study comparing two leading treatments for metastatic prostate cancer may help doctors choose the right drug for each patient, said a Rutgers Cancer Institute physician-scientist whose invited ...
Aug 10, 2026
0
7
Melanoma treatment mystery gets new answers from mathematical model
New research from the University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, ...
Aug 10, 2026
0
5
Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy
The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.
Aug 10, 2026
0
3
Study suggests experimental drug dismantles 2 key proteins that help tumors survive, adapt and resist treatment
Scientists from Roswell Park Comprehensive Cancer Center report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades the proteins DDX5 and UbE2T, two ...
Aug 10, 2026
0
7
Liver cancer experts co-author new treatment framework for hepatocellular carcinoma
Liver cancer experts at the Johns Hopkins Kimmel Cancer Center and 16 other cancer centers have compiled new guidance on the best treatments for hepatocellular carcinoma (HCC) in North America. The resource, called BEACON-HCC, ...
Aug 10, 2026
0
1
Blood test could speed lymphoma diagnosis in resource-limited settings
For people with lymphoma, getting the right diagnosis can be a race against time.
Aug 10, 2026
0
2
Protein 'switch' determines whether liposarcoma cells will become aggressive
New research from an expert in cancer biology explains what triggers liposarcoma cells to become more or less aggressive and identifies potential targets that could keep aggressive tumors in check. A study led by Blake Wilde, ...
Aug 9, 2026
0
17
Dense breasts or breast cancer in the family? What screening changes mean for you
The way women are screened for breast cancer in Australia is changing. According to a newly released review, this means moving away from screening based largely on someone's age. Instead, screening would be tailored according ...
Aug 9, 2026
0
22
